Innovation & intellectual property · 06/06/2005Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension to Atamestane Patent
Summary
The U.S. Patent and Trademark Office has issued a certificate for a second one-year extension of the term of U.S. Patent No. 4,591,585, which covers the medication atamestane.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →